MAAT INDEX

CLAIM #31316 · IBM (IBM) · 2025Q3 earnings call · Oct 22, 2025 · due Dec 31, 2026

Because of the Hashi bookings, which are significantly ahead of where we had planned them to be, I expect we'll continue to see growth out of Hashi through 2026 as well.

Arvind Krishna · CEO

PENDING
graded after results covering Dec 31, 2026 are reported

How to check this claim

Look at: Revenue growth attributable to HashiCorp product line (within Automation segment), year-over-year

It came true if: Positive year-over-year growth reported for HashiCorp/Automation-related revenue in fiscal year 2026

Where: IBM management commentary / segment disclosures on quarterly earnings calls through FY2026

In context

ouched on transaction processing, or mainframe software. We have seen this happen multiple times. In the first couple of quarters of a new cycle, TP tends to come down because people are very much focused on getting their hardware capacity. As that hardware capacity gets deployed, then the TP revenue begins to come up, along with some of the ELA cycle dynamics that are there. And we begin to see that. So I expect to see TP grow. Not quite in double digits to be clear, but let's call it low single digits for sure into next year. Automation has been growing in this last quarter at 22%. Yes, the HashiCorp acquired revenue was a piece of it. And as you point out, that'll go away in the second quarter. However, the acquired properties we have tend to provide continued growth for quite a while. Because of the Hashi bookings, which are significantly ahead of where we had planned them to be, I expect we'll continue to see growth out of Hashi through 2026 as well. Now not quite as much as an acquired growth, but I do expect that we'll continue to see automation in the double digits for sure. If but maybe not north of '20. And we've continued to see the data and AI portfolio grow in the mid to high single digits. Now that does put aside what other acquisitions we will do. Part of our model for software is we'll get a couple of points of growth from acquired revenue and we see a good market for targets, yes, that is yet to play out. But in the current regulatory environment, combined with what we can see out there, expect that we should be able to do that as well. So that was sort of giving you color on the portfolio and the different pieces I'll ask Jim to get into them closing it back up in terms of sort of what is the organic and inorganic and ove

Verify independently

SEC filings for IBM · Claim quote is verbatim from the 2025Q3 earnings call.